TrialAntimicrobial agents and chemotherapy2020

Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation.

Johan Maertens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.